Skip to main content
NCD 160.22 · version 3

NCD 160.22: Ambulatory EEG Monitoring - RETIRED

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 160.22

Benefit category
Diagnostic Tests (other)
Effective date
04/10/2023
Implemented 04/10/2023
Transmittal
Transmittal 11892
Versions published
3
Manual section
160
Nervous System, NCD Manual (Pub. 100-03) chapter 1 part 2

TL;DR

NCD 160.22 sets Medicare's national policy for ambulatory eeg monitoring - retired under the benefit category "Diagnostic Tests (other)", effective 04/10/2023 and implemented 04/10/2023. (Rev. 11892; Issued: 03-09-23; Effective: 04-10-23; Implementation: 04-10-23) It has been revised 2 times since publication and binds every Medicare Administrative Contractor nationally.

Item or service described

Ambulatory, or 24-hour electroencephalographic (EEG) monitoring is accomplished by a cassette recorder that continuously records brain wave patterns during 24 hours of a patient's routine daily activities and sleep. The monitoring equipment consists of an electrode set, preamplifiers, and a cassette recorder. The electrodes attach to the scalp, and their leads are connected to a recorder, usually worn on a belt.

Indications and limitations of coverage

160.22 – Ambulatory EEG Monitoring (RETIRED)

(Rev. 11892; Issued: 03-09-23; Effective: 04-10-23; Implementation: 04-10-23)

Effective January 1, 2023, NCD 160.22 is retired.

Text reproduced from the CMS Medicare Coverage Database record for NCD 160.22 version 3. View the original on cms.gov.

Local policies that build on this NCD

1 active Local Coverage Determination cites NCD 160.22 among its related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 160.22

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 160.22, 1 of them with a covered ICD-10-CM list, from 1 contractor. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 160.22
ContractorArticles
Wellpoint FederalA57030

A57030: Billing and Coding: EEG – Ambulatory Monitoring

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

73 covered ICD-10-CM codes; 23 procedure codes: 95700, 95705, 95706, 95707, 95708, 95709, 95710, 95711, 95712, 95713, 95714, 95715 and 11 more. Local policy: L33399 EEG – Ambulatory Monitoring. Check a diagnosis for 95700.

First covered codes: F44.4 Conversion disorder with motor symptom or deficit; F44.5 Conversion disorder with seizures or convulsions; F44.6 Conversion disorder with sensory symptom or deficit; F44.7 Conversion disorder with mixed symptom presentation; G40.001 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus; G40.009 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus; …

Revision history

02/2023 Transmittal 11824 issued January 27, 2023, is being rescinded and replaced by Transmittal 11865, dated, February 16, 2023, to add the Spanish version of MSN Message 18.29 to the IOM for publication 100-04. This correction does not make any revisions to the companion Pubs.100-02 or 100-03; all revisions are associated with Pub. 100-04. All other information remains the same.(Rev.11824; Issued: 01-27-23; Effective: 01-01-23; Implementation: 02-27-23) ( TN 11865 ) (CR13017)

01/2023 160.22 Ambulatory EEG Monitoring (Retired)

(Rev.11824; Issued: 01-27-23; Effective: 01-01-23; Implementation: 02-27-23)

Effective January 1, 2023, the Centers for Medicare & Medicaid Services removed the national coverage determination (NCD) for Ambulatory EEG Monitoring. In the absence of an NCD, coverage determinations will be made by the Medicare Administrative Contractors under section 1862(a)(1)(A) of the Social Security Act. ( TN 11824 ) (CR13017)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 160.22

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 160.22

What does NCD 160.22 cover?

160.22 – Ambulatory EEG Monitoring (RETIRED) The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 160.22 take effect?

The current version (3) is effective 04/10/2023, implemented 04/10/2023, published in transmittal 11892. CMS lists 3 versions of this NCD.

Does a Local Coverage Determination override NCD 160.22?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.